|
|
Other links at Articles > Business of Medicine |
| 3. |
Intensive-Glycemic-Control Arm of ACCORD Stopped
|
|
|
The blood-glucose-lowering part of the ACCORD trial in patients with type 2 diabetes at especially high risk of heart disease has been stopped prematurely because of a higher rate of mortality in the patients in the intensive arm vs that in the standard arm. Heartwire
|
| 5. |
U.S. Democrats Object to Plan on Drug Label Changes
|
|
|
Eight U.S. congressional Democrats urged the U.S. Food and Drug Administration on Wednesday to reconsider a plan that the lawmakers said would shield companies from liability rather than protect patients. Reuters Health Information
|
|
|